SCHEMBL7612341

SCHEMBL7612341

[CH2]NS(=O)(=O)CCCCCC

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.50
CA2 P00918 3/20 0.45
RELA Q04206 4/20 0.44
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
KMT2A Q03164 1/20 0.42
PPARA Q07869 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1830515 0.98 FAAH (0.46) FAAHCA2RELAMEN1ALDH1A1
SCHEMBL604853 0.90
SCHEMBL27876248 0.83 FAAH (0.52) FAAHCA2RELAPPARAKDM4E
SCHEMBL10226704 0.80 FAAH (0.54) FAAHCA2RELAPPARAKDM4E
SCHEMBL6501307 0.80 FAAH (0.54) FAAHCA2RELAPPARAKDM4E
SCHEMBL606982 0.79
SCHEMBL77046 0.78 FAAH (0.52) FAAHCA2RELA
SCHEMBL1679338 0.78 FAAH (0.52) FAAHCA2RELA
SCHEMBL3261095 0.78 FAAH (0.52) FAAHCA2RELA
SCHEMBL6780714 0.78 FAAH (0.52) FAAHCA2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9187450-B2 Substituted pyridine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-11-17 US disclosed
EP-2592076-B1 SUBSTITUTED PYRIDINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-05-13 EP disclosed
US-20140213549-A9 Substituted Pyridine Compound UBE INDUSTRIES, LTD. (JP) 2014-07-31 US disclosed
US-20140005143-A2 Substituted PyridineCompound DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-01-02 US disclosed
EP-2592076-A1 SUBSTITUTED PYRIDINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-05-15 EP disclosed
US-20130109653-A1 Substituted Pyridine Compound UBE INDUSTRIES, LTD. (JP) 2013-05-02 US disclosed
EP-1230210-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-08-14 EP disclosed
WO-2001036375-A1 AMINOALCOHOL DERIVATIVES USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-05-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213549-A9 Substituted Pyridine Compound CETP, MTTP, PRCP FAAH 67/4885CA2 607/4885RELA 2289/4885
US-20140005143-A2 Substituted PyridineCompound CETP, MTTP, CES1 FAAH 64/4885CA2 787/4885RELA 3039/4885
US-20130109653-A1 Substituted Pyridine Compound CETP, MTTP, PRCP FAAH 67/4885CA2 607/4885RELA 2289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.